Latest Microbicides for sexually transmitted diseases Stories
CONRAD is pleased to join in congratulating the Global iPrEx study team for their successful trial of oral tenofovir (TDF) with emtricitabine (FTC) for HIV prevention.
JOHANNESBURG and WASHINGTON, Nov.
NEW YORK, Sept.
CAPRISA 004 trial shows moderate protection against transmission of virus JOHANNESBURG and WASHINGTON, July 19 /PRNewswire-USNewswire/ -- Results of an advanced clinical trial of an antiretroviral-based microbicide candidate are being announced at the International AIDS Conference in Vienna, Austria.
VIENNA, July 19 /PRNewswire-USNewswire/ -- "This is a historic day for HIV prevention research.
Researchers from Boston University School of Medicine (BUSM) have identified two molecules that when activated by drugs, can inhibit a number of specific aspects of HIV transmission.
WASHINGTON, June 8 /PRNewswire/ -- The nonprofit International Partnership for Microbicides (IPM) today announced the initiation of the first trial among women in Africa testing a vaginal ring containing an antiretroviral drug (ARV) that could one day be used to prevent HIV transmission during sex.
BETHLEHEM, Pa., Jan. 26 /PRNewswire/ -- Particle Sciences, a leading drug development CRO, will share formulation, analytic and production responsibilities in an effort to develop a vaginally administered microbicide, a product specifically designed to prevent the sexual transmission of HIV.
Funding and Support for HIV Prevention Research Must Continue NEW YORK, Dec.
Scientists at Albert Einstein College of Medicine of Yeshiva University have devised a laboratory test for predicting whether microbicides against HIV are safe for human use.
- a slit in a tire to drain away surface water and improve traction.